Anti-vimentin Antibody-associated Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-07-03
Clinical Trial Update: Efficacy and Safety of Rituximab in the Treatment of Anti-Vimentin Antibody-associated Diseases [Phase 4]
Phase 4 study evaluating rituximab for Anti-Vimentin Antibody-associated Diseases, including Meningoencephalomyelitis Associated With Viment…